Sonoma Pharmaceuticals, Inc. (SNOA)
1.32
-0.01
(-0.75%)
USD |
NASDAQ |
Sep 09, 16:00
1.32
0.00 (0.00%)
After-Hours: 16:29
Sonoma Pharmaceuticals Price to Book Value : 0.9580 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.9653 |
| September 04, 2026 | 0.9617 |
| September 03, 2026 | 0.958 |
| September 02, 2026 | 0.9363 |
| September 01, 2026 | 0.9363 |
| August 31, 2026 | 0.9363 |
| August 28, 2026 | 0.9508 |
| August 27, 2026 | 0.9653 |
| August 26, 2026 | 1.002 |
| August 25, 2026 | 0.9798 |
| August 24, 2026 | 0.9725 |
| August 21, 2026 | 0.9725 |
| August 20, 2026 | 0.9725 |
| August 19, 2026 | 0.9871 |
| August 18, 2026 | 0.9435 |
| August 17, 2026 | 0.958 |
| August 14, 2026 | 0.9435 |
| August 13, 2026 | 0.9725 |
| August 12, 2026 | 0.9943 |
| August 11, 2026 | 0.9943 |
| August 10, 2026 | 0.9363 |
| August 07, 2026 | 1.045 |
| August 06, 2026 | 0.9072 |
| August 05, 2026 | 0.8201 |
| August 04, 2026 | 0.8709 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.8129 |
| July 31, 2026 | 0.7984 |
| July 30, 2026 | 0.8201 |
| July 29, 2026 | 0.7984 |
| July 28, 2026 | 0.8274 |
| July 27, 2026 | 0.8346 |
| July 24, 2026 | 0.8274 |
| July 23, 2026 | 0.8419 |
| July 22, 2026 | 0.8419 |
| July 21, 2026 | 0.8673 |
| July 20, 2026 | 0.8492 |
| July 17, 2026 | 0.8782 |
| July 16, 2026 | 0.8855 |
| July 15, 2026 | 0.8855 |
| July 14, 2026 | 0.8927 |
| July 13, 2026 | 0.9145 |
| July 10, 2026 | 0.9145 |
| July 09, 2026 | 0.9145 |
| July 08, 2026 | 0.90 |
| July 07, 2026 | 0.8927 |
| July 06, 2026 | 0.9072 |
| July 02, 2026 | 0.8782 |
| July 01, 2026 | 0.8782 |
| June 30, 2026 | 0.8927 |
| June 29, 2026 | 0.715 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.717 |
| Corcept Therapeutics, Inc. | 17.68 |
| Veru, Inc. | 1.502 |
| Johnson & Johnson | 7.572 |
| Eli Lilly & Co. | 31.24 |
Price to Book Value Related Metrics
| PS Ratio | 0.1351 |
| Price | 1.32 |
| Earnings Yield | -92.24% |
| Market Cap | 6.317M |